Concord Wealth Partners’s AngioDynamics ANGO Stock Holding History

Concord Wealth Partners’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-388	Closed	-$8K	–	201
2022 Q2	$8K	Sell	388 -2,014	-84%	-$41.2K	﹤0.01%	721
2022 Q1	$52K	Sell	2,402 -994	-29%	-$22.6K	0.01%	428
2021 Q4	$94K	Buy	3,396 +2,539	+296%	+$70.1K	0.02%	317
2021 Q3	$22K	Sell	857 -1,803	-68%	-$48.2K	0.01%	359
2021 Q2	$72K	Buy	2,660 +1,893	+247%	+$46.2K	0.02%	287
2021 Q1	$18K	Buy	+767	New	+$15.5K	0.01%	485

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Concord Wealth Partners's ANGO Position: Q3 2022 in Review

Concord Wealth Partners sold out of AngioDynamics (ANGO) in Q3 2022, closing a stake of 388 shares — an estimated $8K sold.

Concord Wealth Partners first reported a position in ANGO in Q1 2021 and held it in 6 quarters. The position peaked at $94K in Q4 2021. 149 funds tracked by Wall St. Rank hold ANGO as of Q3 2022.

Concord Wealth Partners reported no remaining AngioDynamics position as of Q3 2022 after selling out during the quarter.
Concord Wealth Partners sold 388 AngioDynamics shares in Q3 2022, an estimated $8K.
Concord Wealth Partners first reported a position in AngioDynamics in Q1 2021 and held it in 6 quarters.
Concord Wealth Partners's AngioDynamics position peaked at $94K in Q4 2021.
149 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2022.

Based on Concord Wealth Partners's 13F filing for Q3 2022, filed 10 Nov 2022.